510(k) Report

510(k) · Cleared

Cleared

Instant-View LH Ovulation Predicting Test

K022829510(k) AbbreviatedCleared Nov 5, 200271-day reviewClass I21 CFR 862.1485

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alfa Scientific Designs, Inc. · CEP Radioimmunoassay, Luteinizing Hormone

Cleared on Nov 5, 2002 as substantially equivalent to K981271 (Unipath, Ltd., 1998) after a 71-day review. Its family tree reaches back 1 generation to 1998.

Decided
Nov 5, 2002
Review
71 days
Class
Class I
Product code
CEP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K981271 (1998). No later device cites it as a predicate yet.

K981271 · Clearplan Easy Ovulation Test · Unipath, Ltd. · 199819961998200020022004
K981271 · Clearplan Easy Ovulation Test · Unipath, Ltd. · 19980
  1. Root · 1 generation backK981271 Clearplan Easy Ovulation TestUnipath, Ltd. · 1998
  2. This deviceK022829 Instant-View LH Ovulation Predicting TestAlfa Scientific Designs, Inc. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K981271Clearplan Easy Ovulation TestUnipath, Ltd.1998—
0 (this device)K022829Instant-View LH Ovulation Predicting TestAlfa Scientific Designs, Inc.2002—
FIG. 1 — Lineage of K022829, 1998–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981271Clearplan Easy Ovulation Test
Summary page 1
…of Summary Preparation October 9, 2002 Predicate Device CLEARPLAN EasyTM One-Step Ovulation Predictor (K98 1271) Device Description This test is a one-step lateral flow chromatographic immunoassay.…
Unipath, Ltd.1998—

Also cleared against K981271: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 4 other devices also cite its predicate K981271.

How does its category compare?

All CEP devices

CEP Radioimmunoassay, Luteinizing Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CEP

FDA has decided no CEP device since 2007.

Median 510(k) review, days · CEP

Too few CEP 510(k)s in any year since 2007 to give a median.

Recalls per year · CEP

1in 2022

2012: 12021: 12022: 1
2007high 1 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEP

1in 2023

2007: 52008: 22011: 32014: 172015: 12023: 1
2007high 17 (2014) · low 0 (2009)2025

MAUDE reports naming product code CEP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—05
20080—02
20090—00
20100—00
20110—03
20120—10
20130—00
20140—017
20150—01
20160—00
20170—00
20180—00
20190—00
20200—00
20210—10
20220—10
20230—01
20240—00
20250—00
20260—0—

What is it indicated for?

The Instant-View TM LH Ovulation Predicting Test is a qualitative immunoassay for the detection of human Luteinizing Hormone (hLH) in human urine to predict the occurrence of ovulation. It is for health care professional use, including at the point of care (physician’s office labs, doctor’s offices) .

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K022829: Instant-View LH Ovulation Predicting Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K022829

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026